Showing results (1-10 of 244) with videos related to
Sort By:
Pageof 25
Expert Opinion on Investigational Drugs|July 24, 2013
Investigational anticoagulants for hematological conditions: a new generation of therapiesGentian Denas, Vittorio PengoExpert Opinion on Drug Safety|March 7, 2012
Current anticoagulant safetyGentian Denas, Vittorio PengoSeminars in Thrombosis and Hemostasis|June 21, 2022
Antiphospholipid Syndrome in Patients with Venous ThromboembolismVittorio Pengo, Gentian DenasHematology. American Society of Hematology. Education Program|December 4, 2018
Optimizing quality care for the oral vitamin K antagonists (VKAs)Vittorio Pengo, Gentian DenasThrombosis Research|July 15, 2018
Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspectiveVittorio Pengo, Gentian DenasExpert Opinion on Pharmacotherapy|May 27, 2023
New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyondGiovanni Santostasi, Gentian Denas, Vittorio PengoExpert Opinion on Pharmacotherapy|January 8, 2019
The benefit of betrixaban for the extended thromboprophylaxis in acutely ill medical patientsDaniele Scarpa, Gentian Denas, Luciano Babuin, et al.European Journal of Internal Medicine|January 15, 2023
Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertensionRui Zhu, Gang-Yi Cheng, Gentian Denas, et al.Blood Reviews|December 20, 2020
Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic reviewChunyan Cheng, Gang-Yi Cheng, Gentian Denas, et al.Pageof 25